<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35909024</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-499X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Trends in molecular medicine</Title><ISOAbbreviation>Trends Mol Med</ISOAbbreviation></Journal><ArticleTitle>Translation of gene therapy strategies for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>795</StartPage><EndPage>796</EndPage><MedlinePgn>795-796</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molmed.2022.07.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1471-4914(22)00177-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demarest</LastName><ForeName>Tyler G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Spark Therapeutics, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biferi</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Spark Therapeutics, Philadelphia, PA 19104, USA. Electronic address: maria.graziabiferi@sparktx.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Mol Med</MedlineTA><NlmUniqueID>100966035</NlmUniqueID><ISSNLinking>1471-4914</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AAV</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ASO</Keyword><Keyword MajorTopicYN="N">clinical trials (CT)</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword></KeywordList><CoiStatement>Declaration of interests No interests are declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>31</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35909024</ArticleId><ArticleId IdType="doi">10.1016/j.molmed.2022.07.001</ArticleId><ArticleId IdType="pii">S1471-4914(22)00177-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>